Voltaren and Nephrosclerosis - a phase IV clinical study of FDA data

Summary:

Nephrosclerosis is reported as a side effect among people who take Voltaren (diclofenac sodium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Orudis, and have Back pain.

The phase IV clinical study analyzes which people have Nephrosclerosis when taking Voltaren. It is created by eHealthMe based on reports of 81,356 people who have side effects when taking Voltaren from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Nephrosclerosis?

Nephrosclerosis (hardening of the kidney due to renovascular disease) is found to be associated with 341 drugs and 314 conditions by eHealthMe. Check the latest studies of Nephrosclerosis.

On Aug, 11, 2026

81,356 people reported to have side effects when taking Voltaren.
Among them, 15 people (0.02%) have Nephrosclerosis.

Among these 15 people:

How long have people been on Voltaren when they have Nephrosclerosis? *

What is the gender of people who have Nephrosclerosis when taking Voltaren? *

female: 40 %
male: 60 %

What is the age of people who have Nephrosclerosis when taking Voltaren? *

What are other drugs people take besides Voltaren? *

What are other side effects people have besides Nephrosclerosis? *

Acute Kidney Failure: 9 people, 60.00%
Interstitial Nephritis (inflammation of the kidney): 7 people, 46.67%
Blood Urea Increased: 5 people, 33.33%
Blood Creatinine Increased: 5 people, 33.33%
Renal Tubular Atrophy (wasting of kidney tubules): 4 people, 26.67%
Retroperitoneal Fibrosis (a rare disorder that occurs when extra fibrous tissue forms in the area behind the stomach and intestines): 4 people, 26.67%
Ureteric Stenosis (abnormal narrowing or contraction of a duct or canal): 4 people, 26.67%
Blood Lactate Dehydrogenase Increased: 3 people, 20.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 20.00%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 33.33%
Back Pain: 5 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
Oedema Peripheral (superficial swelling): 2 people, 13.33%
Joint Pain: 2 people, 13.33%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 13.33%
Gastric Erosions (gradual destruction of surface layer of the membrane lining the stomach): 2 people, 13.33%
Nail Tinea (fungal infection of nail): 1 person, 6.67%
Metastases To Bone (cancer spreads to bone): 1 person, 6.67%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and have Nephrosclerosis?

- Check whether Nephrosclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Voltaren:

Voltaren (82,346 reports)

Nephrosclerosis treatments and more:

Nephrosclerosis (2,137 reports)

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephrosclerosis:

Nephrosclerosis (341 drugs)

Browse all the conditions that are associated with Nephrosclerosis:

Nephrosclerosis (314 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium (the active ingredients of Voltaren) and Voltaren (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.